Medications

US experts review heart attack risk of diabetes drug

GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts.

Cardiology

Argument for coverage of cardiac rehab, counseling for stable CHF

(HealthDay)—Cardiac rehabilitation (CR) exercise training and chronic heart failure self-care counseling provide significant clinical benefits to individuals with stable chronic heart failure, according to a review published ...

Cardiology

Nocturnal respiratory rate predicts cardiac risk after MI

(HealthDay)—Among survivors of acute myocardial infarction (MI), nocturnal respiratory rate (NRR) is significantly associated with cardiac mortality, particularly non-sudden cardiac death, according to research published ...

Surgery

Severe anemia linked to poorer heart surgery outcomes

(HealthDay)—Adults undergoing cardiac surgery who have moderate-to-severe preoperative anemia have significantly increased morbidity and mortality compared with non-severely anemic patients, according to research published ...

Cardiology

Critical pediatric heart deaths drop by 24% at PC4 hospitals

Eighteen pediatric heart centers were able to significantly reduce deaths and improve care for children with critical heart conditions after committing to transparent data sharing between one another, a new study suggests.

Cardiology

ASA: patients undergoing surgery should stay on statins

(HealthDay)—Discontinuing statins before non-cardiac surgery is unnecessary and may increase the risk of death following the operation, researchers report. The findings were to be presented at the annual meeting of the ...

page 5 from 9